ID   PPR3A_HUMAN             Reviewed;        1122 AA.
AC   Q16821; A0AVQ2; A4D0T6; O43476; Q75LN8; Q7KYM8; Q86UI6;
DT   13-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   15-JUN-2010, sequence version 3.
DT   12-APR-2017, entry version 129.
DE   RecName: Full=Protein phosphatase 1 regulatory subunit 3A;
DE   AltName: Full=Protein phosphatase 1 glycogen-associated regulatory subunit;
DE   AltName: Full=Protein phosphatase type-1 glycogen targeting subunit;
DE            Short=RG1;
GN   Name=PPP1R3A; Synonyms=PP1G;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), TISSUE
RP   SPECIFICITY, AND VARIANTS MET-451; LYS-476; HIS-882; SER-883 AND
RP   TYR-905.
RC   TISSUE=Skeletal muscle;
RX   PubMed=9726244; DOI=10.2337/diabetes.47.9.1519;
RA   Xia J., Scherer S.W., Cohen P.T.W., Majer M., Xi T., Norman R.A.,
RA   Knowler W.C., Bogardus C., Prochazka M.;
RT   "A common variant in PPP1R3 associated with insulin resistance and
RT   type 2 diabetes.";
RL   Diabetes 47:1519-1524(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS MET-451;
RP   LYS-476 AND HIS-882.
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   MET-451; LYS-476 AND HIS-882.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-1122 (ISOFORM 1), VARIANTS MET-451;
RP   LYS-476 AND HIS-882, AND VARIANT NIDDM GLU-931.
RC   TISSUE=Skeletal muscle;
RX   PubMed=7926294; DOI=10.2337/diabetes.43.10.1234;
RA   Chen Y.H., Hansen L., Chen M.X., Bjorbaek C., Vestergaard H.,
RA   Hansen T., Cohen P.T.W., Pederson O.;
RT   "Sequence of the human glycogen-associated regulatory subunit of type
RT   I protein phosphatase and analysis of its coding region and mRNA level
RT   in muscle from patients with non-insulin-dependent diabetes.";
RL   Diabetes 43:1234-1241(1994).
RN   [6]
RP   VARIANT TYR-905.
RX   PubMed=7581368; DOI=10.1093/hmg/4.8.1313;
RA   Hansen L., Hansen T., Vestergaard H., Bjorbaek C., Echwald S.M.,
RA   Clausen J.O., Chen Y.H., Chen M.X., Cohen P.T.W., Pedersen O.;
RT   "A widespread amino acid polymorphism at codon 905 of the glycogen-
RT   associated regulatory subunit of protein phosphatase-1 is associated
RT   with insulin resistance and hypersecretion of insulin.";
RL   Hum. Mol. Genet. 4:1313-1320(1995).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] ALA-554.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Seems to act as a glycogen-targeting subunit for PP1.
CC       PP1 is essential for cell division, and participates in the
CC       regulation of glycogen metabolism, muscle contractility and
CC       protein synthesis. Plays an important role in glycogen synthesis
CC       but is not essential for insulin activation of glycogen synthase
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with PPP1CC catalytic subunit of PP1, and
CC       associates with glycogen. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass membrane
CC       protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q16821-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16821-2; Sequence=VSP_011585, VSP_011586;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC   -!- TISSUE SPECIFICITY: Skeletal muscle and heart.
CC       {ECO:0000269|PubMed:9726244}.
CC   -!- DOMAIN: The CBM21 domain is known to be involved in the
CC       localization to glycogen and is characteristic of some regulatory
CC       subunit of phosphatase complexes.
CC   -!- PTM: Phosphorylation at Ser-46 by ISPK stimulates the
CC       dephosphorylation of glycogen synthase and phosphorylase kinase.
CC       {ECO:0000250}.
CC   -!- DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM)
CC       [MIM:125853]: A multifactorial disorder of glucose homeostasis
CC       caused by a lack of sensitivity to the body's own insulin.
CC       Affected individuals usually have an obese body habitus and
CC       manifestations of a metabolic syndrome characterized by diabetes,
CC       insulin resistance, hypertension and hypertriglyceridemia. The
CC       disease results in long-term complications that affect the eyes,
CC       kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:7926294}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAS07492.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF024578; AAB94596.1; -; Genomic_DNA.
DR   EMBL; AF024576; AAB94596.1; JOINED; Genomic_DNA.
DR   EMBL; AF024577; AAB94596.1; JOINED; Genomic_DNA.
DR   EMBL; AF024579; AAB94597.1; -; mRNA.
DR   EMBL; AC092465; AAS07492.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC093598; AAP22361.1; -; Genomic_DNA.
DR   EMBL; CH236947; EAL24370.1; -; Genomic_DNA.
DR   EMBL; BC126451; AAI26452.1; -; mRNA.
DR   EMBL; BC126453; AAI26454.1; -; mRNA.
DR   EMBL; X78578; CAA55316.1; -; mRNA.
DR   CCDS; CCDS5759.1; -. [Q16821-1]
DR   PIR; I38127; I38127.
DR   RefSeq; NP_002702.2; NM_002711.3. [Q16821-1]
DR   UniGene; Hs.458309; -.
DR   ProteinModelPortal; Q16821; -.
DR   SMR; Q16821; -.
DR   BioGrid; 111499; 45.
DR   IntAct; Q16821; 2.
DR   STRING; 9606.ENSP00000284601; -.
DR   CAZy; CBM21; Carbohydrate-Binding Module Family 21.
DR   iPTMnet; Q16821; -.
DR   PhosphoSitePlus; Q16821; -.
DR   BioMuta; PPP1R3A; -.
DR   DMDM; 298286906; -.
DR   EPD; Q16821; -.
DR   PaxDb; Q16821; -.
DR   PeptideAtlas; Q16821; -.
DR   PRIDE; Q16821; -.
DR   DNASU; 5506; -.
DR   Ensembl; ENST00000284601; ENSP00000284601; ENSG00000154415. [Q16821-1]
DR   Ensembl; ENST00000284602; ENSP00000284602; ENSG00000154415. [Q16821-2]
DR   GeneID; 5506; -.
DR   KEGG; hsa:5506; -.
DR   UCSC; uc010ljy.2; human. [Q16821-1]
DR   CTD; 5506; -.
DR   DisGeNET; 5506; -.
DR   GeneCards; PPP1R3A; -.
DR   H-InvDB; HIX0033522; -.
DR   HGNC; HGNC:9291; PPP1R3A.
DR   MalaCards; PPP1R3A; -.
DR   MIM; 125853; phenotype.
DR   MIM; 600917; gene.
DR   neXtProt; NX_Q16821; -.
DR   OpenTargets; ENSG00000154415; -.
DR   PharmGKB; PA33651; -.
DR   eggNOG; KOG3986; Eukaryota.
DR   eggNOG; ENOG4111FT1; LUCA.
DR   GeneTree; ENSGT00530000062978; -.
DR   HOVERGEN; HBG053657; -.
DR   InParanoid; Q16821; -.
DR   KO; K07189; -.
DR   OMA; LFTCQET; -.
DR   OrthoDB; EOG091G00OC; -.
DR   PhylomeDB; Q16821; -.
DR   TreeFam; TF105537; -.
DR   SIGNOR; Q16821; -.
DR   GeneWiki; PPP1R3A; -.
DR   GenomeRNAi; 5506; -.
DR   PRO; PR:Q16821; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000154415; -.
DR   CleanEx; HS_PPP1R3A; -.
DR   ExpressionAtlas; Q16821; baseline and differential.
DR   Genevisible; Q16821; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR005036; CBM21_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   Pfam; PF03370; CBM_21; 1.
DR   PROSITE; PS51159; CBM21; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Carbohydrate metabolism; Complete proteome;
KW   Diabetes mellitus; Disease mutation; Glycogen metabolism; Membrane;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1   1122       Protein phosphatase 1 regulatory subunit
FT                                3A.
FT                                /FTId=PRO_0000071500.
FT   TRANSMEM   1078   1098       Helical. {ECO:0000255}.
FT   DOMAIN      122    230       CBM21. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00491}.
FT   MOTIF        62     65       PP1-binding motif.
FT   MOD_RES      38     38       Phosphoserine; by GSK3. {ECO:0000250}.
FT   MOD_RES      42     42       Phosphoserine; by GSK3. {ECO:0000250}.
FT   MOD_RES      46     46       Phosphoserine; by PKA and ISPK.
FT                                {ECO:0000250}.
FT   MOD_RES      49     49       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99MR9}.
FT   MOD_RES      56     56       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q99MR9}.
FT   MOD_RES      65     65       Phosphoserine; by PKA. {ECO:0000250}.
FT   MOD_RES     844    844       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99MR9}.
FT   VAR_SEQ      60     74       GTRRVSFADSFGFNL -> ERTRAGACKTMERSS (in
FT                                isoform 2). {ECO:0000303|PubMed:9726244}.
FT                                /FTId=VSP_011585.
FT   VAR_SEQ      75   1122       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9726244}.
FT                                /FTId=VSP_011586.
FT   VARIANT      45     45       G -> S (in dbSNP:rs8192687).
FT                                /FTId=VAR_027929.
FT   VARIANT     231    231       C -> Y (in dbSNP:rs7801819).
FT                                /FTId=VAR_027930.
FT   VARIANT     451    451       V -> M (in dbSNP:rs2974942).
FT                                {ECO:0000269|PubMed:12690205,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7926294,
FT                                ECO:0000269|PubMed:9726244}.
FT                                /FTId=VAR_027931.
FT   VARIANT     476    476       N -> K (in dbSNP:rs2974944).
FT                                {ECO:0000269|PubMed:12690205,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7926294,
FT                                ECO:0000269|PubMed:9726244}.
FT                                /FTId=VAR_027932.
FT   VARIANT     554    554       G -> A (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036287.
FT   VARIANT     627    627       R -> K (in dbSNP:rs35067467).
FT                                /FTId=VAR_057128.
FT   VARIANT     748    748       E -> K (in dbSNP:rs4304271).
FT                                /FTId=VAR_027933.
FT   VARIANT     882    882       L -> H (in dbSNP:rs2974938).
FT                                {ECO:0000269|PubMed:12690205,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7926294,
FT                                ECO:0000269|PubMed:9726244}.
FT                                /FTId=VAR_027934.
FT   VARIANT     883    883       R -> S (in dbSNP:rs1800000).
FT                                {ECO:0000269|PubMed:9726244}.
FT                                /FTId=VAR_019697.
FT   VARIANT     905    905       D -> Y (common polymorphism; can be
FT                                associated with insulin resistance;
FT                                dbSNP:rs1799999).
FT                                {ECO:0000269|PubMed:7581368,
FT                                ECO:0000269|PubMed:9726244}.
FT                                /FTId=VAR_019698.
FT   VARIANT     931    931       A -> E (in NIDDM; dbSNP:rs35449651).
FT                                {ECO:0000269|PubMed:7926294}.
FT                                /FTId=VAR_019699.
SQ   SEQUENCE   1122 AA;  125767 MW;  FACB2CEA7C00E75B CRC64;
     MEPSEVPSQI SKDNFLEVPN LSDSLCEDEE VTFQPGFSPQ PSRRGSDSSE DIYLDTPSSG
     TRRVSFADSF GFNLVSVKEF DCWELPSAST TFDLGTDIFH TEEYVLAPLF DLPSSKEDLM
     QQLQIQKAIL ESTESLLGST SIKGIIRVLN VSFEKLVYVR MSLDDWQTHY DILAEYVPNS
     CDGETDQFSF KIVLVPPYQK DGSKVEFCIR YETSVGTFWS NNNGTNYTFI CQKKEQEPEP
     VKPWKEVPNR QIKGCLKVKS SKEESSVTSE ENNFENPKNT DTYIPTIICS HEDKEDLEAS
     NRNVKDVNRE HDEHNEKELE LMINQHLIRT RSTASRDERN TFSTDPVNFP NKAEGLEKKQ
     IHGEICTDLF QRSLSPSSSA ESSVKGDFYC NEKYSSGDDC THQPSEETTS NMGEIKPSLG
     DTSSDELVQL HTGSKEVLDD NANPAHGNGT VQIPCPSSDQ LMAGNLNKKH EGGAKNIEVK
     DLGCLRRDFH SDTSACLKES TEEGSSKEDY YGNGKDDEEQ RIYLGVNEKQ RKNFQTILHD
     QERKMGNPKI SVAGIGASNR DLATLLSEHT AIPTRAITAD VSHSPRTNLS WEEAVLTPEH
     HHLTSEGSAL GGITGQVCSS RTGNVLRNDY LFQVEEKSGG INSEDQDNSP QHKQSWNVLE
     SQGKSRENKT NITEHIKGQT DCEDVWGKRD NTRSLKATTE ELFTCQETVC CELSSLADHG
     ITEKAEAGTA YIIKTTSEST PESMSAREKA IIAKLPQETA RSDRPIEVKE TAFDPHEGRN
     DDSHYTLCQR DTVGVIYDND FEKESRLGIC NVRVDEMEKE ETMSMYNPRK THDREKCGTG
     NITSVEESSW VITEYQKATS KLDLQLGMLP TDKTVFSENR DLRQVQELSK KTDSDAIVHS
     AFNSDTNRAP QNSSPFSKHH TEISVSTNEQ AIAVENAVTT MASQPISTKS ENICNSTREI
     QGIEKHPYPE SKPEEVSRSS GIVTSGSRKE RCIGQIFQTE EYSVEKSLGP MILINKPLEN
     MEEARHENEG LVSSGQSLYT SGEKESDSSA STSLPVEESQ AQGNESLFSK YTNSKIPYFL
     LFLIFLITVY HYDLMIGLTF YVLSLSWLSW EEGRQKESVK KK
//
